Millennium Management LLC boosted its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) by 105.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 400,374 shares of the company’s stock after purchasing an additional 205,023 shares during the quarter. Millennium Management LLC owned about 0.21% of Aveanna Healthcare worth $1,830,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in AVAH. First Eagle Investment Management LLC bought a new stake in Aveanna Healthcare during the 4th quarter valued at approximately $1,992,000. Jacobs Levy Equity Management Inc. boosted its stake in Aveanna Healthcare by 50.1% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company’s stock valued at $2,437,000 after purchasing an additional 177,856 shares during the period. Swiss National Bank bought a new stake in Aveanna Healthcare during the 4th quarter valued at approximately $434,000. Federated Hermes Inc. boosted its stake in Aveanna Healthcare by 3,047.2% during the 4th quarter. Federated Hermes Inc. now owns 89,665 shares of the company’s stock valued at $410,000 after purchasing an additional 86,816 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in Aveanna Healthcare by 80.5% during the 4th quarter. JPMorgan Chase & Co. now owns 154,703 shares of the company’s stock valued at $707,000 after purchasing an additional 68,989 shares during the period. Institutional investors own 87.96% of the company’s stock.
Insider Buying and Selling at Aveanna Healthcare
In other news, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the completion of the transaction, the insider now directly owns 29,640,756 shares of the company’s stock, valued at approximately $158,874,452.16. This represents a 5.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total value of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares of the company’s stock, valued at approximately $3,184,727.20. The trade was a 14.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,887,612 shares of company stock valued at $26,269,057 in the last quarter. Corporate insiders own 7.80% of the company’s stock.
Aveanna Healthcare Stock Up 2.6%
Analyst Ratings Changes
Several brokerages recently weighed in on AVAH. Truist Financial decreased their target price on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a research note on Friday, April 11th. UBS Group upped their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a report on Friday, May 9th.
Check Out Our Latest Analysis on Aveanna Healthcare
Aveanna Healthcare Profile
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
- Five stocks we like better than Aveanna Healthcare
- Differences Between Momentum Investing and Long Term Investing
- Ulta’s Beautiful Q1 Earnings Report Points to More Gains Ahead
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Top 3 ETFs Defense Hawks Are Buying
- How to Short Nasdaq: An Easy-to-Follow Guide
- Zscaler Will Hit $360 Soon: Here’s the How and Why
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.